CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $330,000 | +41.0% | 23,683 | +4.1% | 0.13% | +104.8% |
| Q4 2016 | $234,000 | +21.2% | 22,749 | +19.1% | 0.06% | +37.0% |
| Q3 2016 | $193,000 | -6.8% | 19,100 | +3.6% | 0.05% | +21.1% |
| Q2 2016 | $207,000 | -88.6% | 18,444 | -86.2% | 0.04% | -85.5% |
| Q1 2016 | $1,819,000 | -7.9% | 133,184 | +27.9% | 0.26% | +23.0% |
| Q4 2015 | $1,975,000 | -72.5% | 104,134 | -72.8% | 0.21% | -69.2% |
| Q3 2015 | $7,174,000 | +835.3% | 382,196 | +641.7% | 0.69% | +822.7% |
| Q2 2015 | $767,000 | +43.1% | 51,527 | +45.6% | 0.08% | +41.5% |
| Q1 2015 | $536,000 | -67.7% | 35,398 | -71.6% | 0.05% | -66.5% |
| Q4 2014 | $1,658,000 | +445.4% | 124,502 | +416.6% | 0.16% | +507.7% |
| Q3 2014 | $304,000 | +86.5% | 24,098 | +49.0% | 0.03% | +100.0% |
| Q2 2014 | $163,000 | – | 16,177 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |